PARTICIPANTS TREATED WITH SENZA5

Clinical trials for PARTICIPANTS TREATED WITH SENZA5 explained in plain language.

Never miss a new study

Get alerted when new PARTICIPANTS TREATED WITH SENZA5 trials appear

Sign up with your email to follow new studies for PARTICIPANTS TREATED WITH SENZA5, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Engineered immune cells under Long-Term watch: will the benefits last?

Disease control Not yet recruiting

This study follows people who have already been treated with Senza5 CART5, a personalized cell therapy that uses a patient's own immune cells engineered to target cancer. The goal is to track long-term safety and how well the treatment continues to control the disease. Participan…

Matched conditions: PARTICIPANTS TREATED WITH SENZA5

Sponsor: Vittoria Biotherapeutics • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

PARTICIPANTS TREATED WITH SENZA5

Get alerted when new PARTICIPANTS TREATED WITH SENZA5 trials appear

Engineered immune cells under Long-Term watch: will the benefits last?